dc.contributor.author |
Abusaif, Sail Nawaf Rashid |
de_DE |
dc.contributor.author |
Jradi, Zeinab |
de_DE |
dc.contributor.author |
Held, Laura |
de_DE |
dc.contributor.author |
Pflugfelder, Annette Dorothee |
de_DE |
dc.contributor.author |
Weide, Benjamin Matthias |
de_DE |
dc.contributor.author |
Meier, Friedegund |
de_DE |
dc.contributor.author |
Garbe, Claus |
de_DE |
dc.contributor.author |
Eigentler, Thomas |
de_DE |
dc.date.accessioned |
2014-02-13T11:03:37Z |
|
dc.date.available |
2014-02-13T11:03:37Z |
|
dc.date.issued |
2013 |
de_DE |
dc.identifier.issn |
0960-8931 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/41669 |
|
dc.language.iso |
en |
en |
dc.publisher |
Lippincott Williams & Wilkins |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1097/CMR.0b013e3283650741 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140116051827_00608 |
de_DE |
utue.publikation.seiten |
396-401 |
de_DE |
utue.personen.roh |
Abusaif, Sail |
de_DE |
utue.personen.roh |
Jradi, Zeinab |
de_DE |
utue.personen.roh |
Held, Laura |
de_DE |
utue.personen.roh |
Pflugfelder, Annette |
de_DE |
utue.personen.roh |
Weide, Benjamin |
de_DE |
utue.personen.roh |
Meier, Friedegund |
de_DE |
utue.personen.roh |
Garbe, Claus |
de_DE |
utue.personen.roh |
Eigentler, Thomas K. |
de_DE |
dcterms.isPartOf.ZSTitelID |
Melanoma Research |
de_DE |
dcterms.isPartOf.ZS-Issue |
5 |
de_DE |
dcterms.isPartOf.ZS-Volume |
23 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |